Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Humanigen stock offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 9,200,000 shares of common stock of…

Nuvei $805 million IPO

Davis Polk advised Nuvei Corporation in connection with its initial public offering of 30,961,539 subordinate voting shares for an aggregate amount of approximately $805 million. The…

Vitru $96 million IPO and Nasdaq listing

Davis Polk advised Vitru Limited in connection with its initial public offering of an aggregate of 6,000,000 common shares of Vitru at a price per common share of $16. The initial public…

JPMorgan Chase $6.8 billion cash tender offer

Davis Polk advised JPMorgan Chase & Co. in connection with its cash tender offer to purchase certain of its senior debt securities in an approximate aggregate amount of $6.8 billion…

American Well $853 million IPO and NYSE listing

Davis Polk advised American Well Corporation (“Amwell”) in connection with its initial public offering of 47,405,555 shares of Class A common stock for approximately $853 million in total…

Chewy $282 million public offering

Davis Polk advised the underwriter in connection with a $282 million public offering of 5,100,000 shares of Class A common stock of Chewy, Inc. In addition, the underwriter has an…

Discovery Communications exchange offers of notes

Davis Polk advised the joint-lead dealer managers and the co-dealer managers in connection with the Rule 144A/Regulation S exchange offers by Discovery Communications, LLC of its 4.000%…

JPMorgan Chase euro medium-term note program

Davis Polk advised JPMorgan Chase & Co. in connection with the update of a Euro medium-term note program under which notes may be issued by JPMorgan Chase & Co. and JPMorgan Chase…
Back to top